Authors Posts by Michael Bolick

Michael Bolick

3 POSTS 0 COMMENTS
Michael Bolick attended his first InnoVenture conference March 2006, and was so inspired by a presentation on carbon-based quantum dots that a few months later he licensed the nanotechnology and founded Selah Technologies to develop a tool to help doctors see cancer during surgery. In 2009, Michael sold Selah Technologies to Lab21, and in 2012, led a management buyout of Lab21's U.S. operations to form Selah Genomics. In 2014, EKF Diagnostics acquired Selah Genomics and retained Michael in his current role as CEO. Bolick remains involved with the community, co-Founding and serving as Chairman of SC BIO, serving as a chairman for the Greenville Chamber's NEXT initiative, as well as for USC's NanoCenter.